Original contribution
Lidocaine in prehospital countershock refractory ventricular fibrillation

https://doi.org/10.1016/S0196-0644(81)80309-5Get rights and content

Drug management of out-of-hospital countershock refractory ventricular fibrillation was evaluated by including 100 mg lidocaine bolus intravenously as the only anti-arrhythmic option in a protocol for use by paramedics. One hundred sixteen patients entered the study by failing to convert from ventricular fibrillation after the sequence of countershock, sodium bicarbonate, and repeat countershock. Sixty-two patients (53%) received lidocaine during the course of attempted resuscitation (Group I); 54 patients (47%) did not receive lidocaine (Group II). The two groups did not have significant differences in response times, patient profiles, or the use of other drugs or procedures. In Group I, 28 patients (45%) remained in ventricular fibrillation on arrival at the hospital, 15 (24%) were admitted to the CCU, and seven (11%) were ultimately discharged. In Group II, 25 patients (46%) remained in ventricular fibrillation on arrival at the hospital, eight (17%) survived to be admitted to the hospital, and one (2%) was ultimately discharged. The ability to convert ventricular fibrillation and the number of short- and long-term survivors did not differ significantly between the two groups. We conclude that a well-documented, controlled study of prehospital drug management of ventricular fibrillation is possible, and that further clinical evaluation of drug use in countershock refractory ventricular fibrillation is needed.

References (17)

There are more references available in the full text version of this article.

Cited by (52)

  • Effectiveness of antiarrhythmic drugs for shockable cardiac arrest: A systematic review

    2018, Resuscitation
    Citation Excerpt :

    The included RCTs were comprised of one study [38] with a large sample (>1000 participants), one study [37] with a medium sized sample (500–999 participants), and twelve studies [29–36,39,30–42] with small samples (<499 participants). In the observational studies, there were four [44,48,49,58] large cohorts (>1000 participants), four [43,50,57,60] medium sized cohorts (500–999 participants), and ten [45–47,51–56,59] small cohorts (<499 participants). The range of mean ages in the included RCT studies was 57–67 years, while in the observational studies it was 55.8–83.3 years.

  • Drugs in Out-of-Hospital Cardiac Arrest

    2018, Cardiology Clinics
    Citation Excerpt :

    Despite the widespread use of lidocaine for this indication, there are limited low-quality data addressing its use in the out-of-hospital setting. An observational study published in 1981 compared the survival of prehospital patients who did or did not receive lidocaine for the treatment of refractory VF.32 This small uncontrolled study (n = 116) found a nonsignificant increase in survival to admission and survival to hospital discharge in patients who received lidocaine.

  • Amiodarone or lidocaine for cardiac arrest: A systematic review and meta-analysis

    2016, Resuscitation
    Citation Excerpt :

    The assessment of risk of bias for non-RCTs performed with the NOS method showed that all the studies had low-risk, scoring 6/9 or above. In particular, scores were higher in the two most recent ones (8/9)14,15 and slightly lower for Herlitz et al. (7/9)25; the lowest score was found for the prospective study (6/9).24 All these studies had no independent blind assessment/record linkage (Supplemental digital content 4).

View all citing articles on Scopus

Presented at the Scientific Assembly of the American College of Emergency Physicians in Las Vegas, Nevada, September 1980.

View full text